Keywords: sanofi-aventis, sales, slow, competition, france-headquartered, europe, leading
Sanofi-Aventis sales slow on competition
Article | 06 February 2006
France-headquartered Sanofi-Aventis, Europe's leading drugmaker, has reported a slow-down in sales for the fourth quarter of 2005 as a result of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
